Colorectal cancer
A cancer that starts in the colon or the rectum, parts of the large bowel. Signs include blood in your poo, changes in your usual bowel habits, tummy pain and losing weight without trying. Surgery is the most common treatment for colon cancer. You may also have chemotherapy, radiotherapy, targeted medicines or immunotherapy. The risk grows with age, and screening tests from about 45 can help find it early, when it may be easier to treat.
Read more about colorectal cancerTrial-stage treatments and research studies you can join
Filters
- Tests calderasib with chemotherapy and cetuximab in colorectal cancer
Tests calderasib with chemotherapy in adults with KRAS G12C colorectal cancer.
Bucharest, RomaniaAlso Cluj-Napoca, Craiova, Iași, Sibiu, TimișoaraAge 18+ - Tests amivantamab with chemotherapy in colorectal cancer that returned or spread
Compares amivantamab plus FOLFIRI against standard treatment in adults with colorectal cancer.
Bucharest, RomaniaAlso Cluj-Napoca, Craiova, IașiAge 18+ - Tests pumitamig with chemotherapy against bevacizumab in colorectal cancer
Compares pumitamig plus chemotherapy with bevacizumab plus chemotherapy in untreated colorectal cancer.
Bucharest, RomaniaAlso Cluj-Napoca, Craiova, IașiAge 18+ - Tests sotorasib with panitumumab and FOLFIRI in colorectal cancer
Compares sotorasib combination treatment with FOLFIRI in adults with KRAS-mutated colorectal cancer.
Bucharest, RomaniaAlso Cluj-Napoca, Craiova, Iași, Ploieşti, TimișoaraAge 18+ - Tests petosemtamab with chemotherapy against cetuximab in left-sided colorectal cancer
Compares petosemtamab plus chemotherapy with cetuximab plus chemotherapy in adults with advanced left-sided colorectal cancer.
Bucharest, RomaniaAlso CraiovaAge 18+ - Monitors blood markers after surgery for colorectal or stomach cancer
Tests whether tracking blood markers helps spot complications early in adults after cancer surgery.
Bucharest, RomaniaAge 18+ - Studying new tests to detect colon cancer early in people at high risk
Studies new low-cost tests for colon cancer detection in high-risk adults across Europe.
Bucharest, RomaniaAge 18+ - Tests sotorasib with chemotherapy in adults with colorectal cancer carrying a KRAS G12C mutation
Tests sotorasib with chemotherapy in adults with metastatic colorectal cancer carrying KRAS G12C.
Bucharest, RomaniaAlso Cluj-Napoca, Craiova, PloieştiAge 18 to 64 - Registry of people treated by endoscopic submucosal dissection for early digestive tract growths
Records people with early growths in stomach, bowel or gullet removed by endoscopic submucosal dissection.
Bucharest, RomaniaAge 18 to 100
Trials that have ended are not listed here, because nobody can join them. Stopped and finished Colorectal cancer trials (research view)
Where treatment stands
In the EU, fruquintinib got its first authorisation in June 2024.
Approved: 26
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 64
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 5
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 2
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.
Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 473 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for colorectal cancer. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in Romania, for you and your family.
We have no organisations for this disease listed in Romania yet. General support there is below.
General support in Romania
- Alianța Română de Prevenție a Suicidului (ARPS) – linia 0800 801 200
Romanian non-profit whose volunteers run a free, confidential suicide crisis line (0800 801 200) for people in crisis and their families.
International organisations
Offer tissue or data
There are three ways to help research move faster.
Approved treatments
26 medicines are approved for colorectal cancer in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.
Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 11 uncertain matches are left out. Other countries' own approvals were not checked.
“Miracle cure” fact checker
Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- Fenbendazole & Colorectal cancer
- NOUS-209 neoantigen vaccine & Colorectal cancer
- CBD (cannabidiol) & Colorectal cancer
- Vitamin C (incl. high-dose) & Colorectal cancer
About colorectal cancer
Sources: NHS, NCI PDQ, MedlinePlus, NCI SEER
A cancer that starts in the colon or the rectum, parts of the large bowel. Signs include blood in your poo, changes in your usual bowel habits, tummy pain and losing weight without trying. Surgery is the most common treatment for colon cancer. You may also have chemotherapy, radiotherapy, targeted medicines or immunotherapy. The risk grows with age, and screening tests from about 45 can help find it early, when it may be easier to treat.
What is it?
Bowel cancer, also called colorectal cancer, is cancer anywhere in the large bowel: the colon or the rectum. The large bowel takes water from food and gets rid of waste. It is one of the most common cancers.
The risk grows with age, and you are more likely to get it if you are over 50. It is most often found in people aged 65 to 74. It is more likely if a close relative has had bowel cancer, or if you have an inherited condition such as Lynch syndrome or familial adenomatous polyposis (FAP). Crohn's disease or ulcerative colitis, bowel polyps (small growths), smoking and being overweight also raise the risk. Eating more fruit and vegetables, less red and processed meat, being active and drinking less alcohol can lower it.
The first signs
Bowel cancer may not cause signs at first.
- changes in their poo that are not usual for them, such as softer poo, diarrhoea or constipation;
- needing to poo more or less often than usual;
- blood in their poo, which can look red or black, or bleeding from the bottom;
- often feeling they need to poo, even just after going to the toilet;
- tummy pain, a lump in the tummy or bloating;
- losing weight without trying.
Feeling very tired or short of breath can be a sign of anaemia, which can be caused by bowel cancer. These signs often have other causes.
How doctors find out
If your family doctor thinks you could have bowel cancer, they send you to a specialist. The main test is a colonoscopy: a thin, bendy tube with a camera looks inside your bowel. It may be uncomfortable but should not hurt, and you are offered a sedative and painkillers. A small piece of the bowel lining (a biopsy) can be taken for testing. Stool tests that look for hidden blood are also used.
If it is cancer, CT, MRI or PET scans, blood tests and gene tests show how far it has spread and whether certain gene changes are involved. This helps your team choose the treatment. A specialist nurse is your main contact during and after treatment.
Current treatment
Surgery, often with chemotherapy or radiotherapy
Will it get worse?
It depends on how big the cancer is, whether it has spread, and your general health. About 23 in 100 bowel cancers have spread to other parts of the body when they are found. The outlook also depends on whether surgery can remove all of the tumour and whether the bowel is blocked.
Advanced bowel cancer can be hard to treat. Then treatment aims to slow the cancer, ease symptoms and help you live longer, and a palliative care team helps with symptoms and comfort. After treatment you have check-ups and tests. A blood test called CEA may be done to see whether the cancer has come back.
Medicines: what helps, and what to watch for
Chemotherapy is medicine that kills cancer cells. You may have it before surgery to shrink the cancer, after surgery to lower the chance of it coming back, instead of surgery, or when the cancer has spread. For advanced bowel cancer, targeted medicines can stop or slow its growth, and immunotherapy helps your immune system attack it. Biomarker tests can help predict how you will respond to certain targeted medicines.
Good to know:
- Most people get some side effects of chemotherapy, but not all of them. Common ones are tiredness, feeling sick, a sore mouth, diarrhoea or constipation, hair loss that is usually temporary, and numbness or tingling in the hands or feet;
- Your team explains the benefits and side effects of each treatment and helps you manage them.
Exercise and diet after surgery
If you have a stoma after surgery (see below), start with gentle activity, such as a short walk, when you feel ready. Once your bowel has settled, go back to your usual, balanced food.
Surgery and radiotherapy
Surgery is the most common treatment at every stage of colon cancer. The surgeon removes the cancer and some of the bowel around it. If the cancer is in a polyp, the polyp is often removed during a colonoscopy. The surgeon may then join the two healthy ends of the bowel back together. If the ends cannot be joined, a stoma (an opening on the outside of the body for waste to pass through) is made, and a bag collects the waste. It can be temporary or permanent.
Radiotherapy uses beams of radiation to kill cancer cells. It is used for cancer in the rectum and for cancer that has spread. If the cancer has spread to the liver, those parts may be removed by surgery. If you cannot have surgery, they may be destroyed with heat or by freezing.
Is there a cure?
Your outlook and treatment depend on the stage of the cancer. Bowel cancer found early, for example through screening, may be easier to treat. Advanced bowel cancer that has spread may be hard to treat and not possible to cure. New treatments are being tested in clinical trials.
Median survival
About 29 to 30 months with first-line treatment, once it has spread
Measured in: Previously untreated metastatic colorectal cancer with KRAS wild-type tumours: the CALGB/SWOG 80405 trial (2,334 patients)
The figures behind it
NCI PDQ (health professional, colon), CALGB/SWOG 80405 (2,334 previously untreated patients with KRAS wild-type metastatic colorectal cancer): median overall survival 29.04 months with chemotherapy plus bevacizumab and 29.93 months with chemotherapy plus cetuximab; the difference was not statistically significant.
Sources
Written in plain words by Frontlight from these pages:
- NHS: Bowel cancer – What is bowel cancer?
- NHS: Bowel cancer – Symptoms
- NCI PDQ: Colon Cancer Treatment (PDQ) – Patient Version
- MedlinePlus: Colorectal Cancer
- NHS: Bowel cancer – Causes
- NCI SEER: Cancer Stat Facts: Colorectal Cancer
- NHS: Bowel cancer – Tests and next steps
- NHS: Bowel cancer – Treatment
- NHS: Chemotherapy – Side effects
- NHS: Colostomy – Recovery and lifestyle changes
- NCI PDQ: Colon Cancer Treatment (PDQ®) – Health Professional Version